XML 104 R79.htm IDEA: XBRL DOCUMENT v3.23.1
Note 3 - Merger (Details Textual)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Jul. 29, 2022
USD ($)
$ / shares
shares
Mar. 31, 2023
USD ($)
$ / shares
shares
Mar. 31, 2022
USD ($)
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
shares
Common Stock, Shares Authorized (in shares) | shares   1,000,000,000   1,000,000,000 23,563,040  
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares   $ 0.0001   $ 0.0001 $ 0.0001  
Preferred Stock, Shares Authorized (in shares) | shares   20,000,000   20,000,000    
Preferred Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares   $ 0.0001   $ 0.0001    
Proceeds from Issuance of Common Stock       $ 2,500 $ 0  
Proceeds From Business Combination and Private Offering       18,094 0  
Payments of Merger Related Costs, Financing Activities   $ 251 $ 122 9,221 $ 61  
Extension and Working Capital Notes [Member]            
Repayments of Debt       861    
Legacy Apexigen [Member]            
Capital Units, Authorized (in shares) | shares 1,020,000,000          
Common Stock, Shares Authorized (in shares) | shares 1,000,000,000          
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares $ 0.0001          
Preferred Stock, Shares Authorized (in shares) | shares 20,000,000          
Preferred Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares $ 0.0001          
Conversion of Stock, Shares Converted (in shares) | shares           145,130,628
Preferred Stock, Convertible, Conversion Ratio 0.102448          
Business Combination, Direct and Incremental Costs Related to Equity Issuance       9,200    
Proceeds From Business Combination and Private Offering       18,094    
Legacy Apexigen [Member] | Extension and Working Capital Notes [Member]            
Repayments of Debt       900    
Legacy Apexigen [Member] | P I P E Investment [Member]            
Stock Redeemed or Called During Period, Shares (in shares) | shares 4,618,607          
Stock Redeemed or Called During Period, Value $ 47,200          
Stock Issued During Period, Shares, New Issues (in shares) | shares 1,452,000          
Business Acquisition, Share Price (in dollars per share) | $ / shares $ 10.00          
Proceeds from Issuance of Common Stock $ 14,500          
Proceeds From Business Combination and Private Offering $ 19,000          
Payments of Merger Related Costs, Financing Activities       $ 9,200